CCM
CLB icon

Cribstone Capital Management’s Core Laboratories CLB Stock Holding History

Cribstone Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-23
Closed -$3K – 709
2018
Q3 		$3K Hold
23
– – ﹤0.01% 674
2018
Q2 		$3K Hold
23
– – ﹤0.01% 686
2018
Q1 		$2K Hold
23
– – ﹤0.01% 710
2017
Q4 		$3K Buy
+23
New +$2.3K ﹤0.01% 734

Other funds holding CLB

WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Cribstone Capital Management's CLB Position: Q4 2018 in Review

Cribstone Capital Management sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 23 shares — an estimated $3K sold.

Cribstone Capital Management first reported a position in CLB in Q4 2017 and held it in 4 quarters. The position peaked at $3K in Q3 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Cribstone Capital Management reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Cribstone Capital Management sold 23 Core Laboratories shares in Q4 2018, an estimated $3K.
  • Cribstone Capital Management first reported a position in Core Laboratories in Q4 2017 and held it in 4 quarters.
  • Cribstone Capital Management's Core Laboratories position peaked at $3K in Q3 2018.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Cribstone Capital Management's 13F filing for Q4 2018, filed 12 Feb 2019.